| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.392 | 13.569 | 9.415 | 12.485 | 13.369 | 11.830 | 30.347 | 31.227 | 41.026 | 38.512 |
| Total Income - EUR | 12.392 | 13.836 | 9.415 | 12.485 | 13.369 | 11.831 | 31.115 | 31.603 | 41.932 | 38.743 |
| Total Expenses - EUR | 4.870 | 6.266 | 5.578 | 3.904 | 3.000 | 2.817 | 4.673 | 5.472 | 15.572 | 16.373 |
| Gross Profit/Loss - EUR | 7.522 | 7.570 | 3.836 | 8.581 | 10.369 | 9.013 | 26.443 | 26.131 | 26.361 | 22.370 |
| Net Profit/Loss - EUR | 7.150 | 7.155 | 3.554 | 8.207 | 9.967 | 8.676 | 25.532 | 25.292 | 25.950 | 21.992 |
| Employees | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Anamorfic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 785 | 3.296 | 795 | 37 | 1.309 | 670 | 4.559 | 2.742 | 1.890 | 5.326 |
| Current Assets | 6.866 | 4.960 | 3.802 | 9.557 | 11.406 | 12.668 | 24.653 | 25.289 | 25.946 | 17.921 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 400 | 0 | 0 | 0 |
| Receivables | 612 | 0 | 0 | 1.985 | 7.187 | 3.797 | 12.593 | 23.332 | 2.858 | 14.560 |
| Cash | 6.254 | 4.960 | 3.802 | 7.572 | 4.219 | 8.872 | 11.659 | 1.957 | 23.087 | 3.361 |
| Shareholders Funds | 7.204 | 7.209 | 3.606 | 8.259 | 10.018 | 8.725 | 25.581 | 25.341 | 25.999 | 22.040 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 447 | 1.048 | 991 | 1.336 | 2.697 | 2.612 | 2.442 | 1.875 | 1.566 | 1.211 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 2.001 | 1.189 | 816 | 271 | 38 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5911 - 5911" | |||||||||
| CAEN Financial Year |
5911
|
|||||||||
Comments - Anamorfic Srl